Opportunity Information: Apply for CDC RFA PS15 150103CONT17
Apply for CDC RFA PS15 150103CONT17
- The Department of Health and Human Services, Centers for Disease Control - NCHHSTP in the health sector is offering a public funding opportunity titled "Tuberculosis Elimination and Laboratory Cooperative Agreement" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.116.
- This funding opportunity was created on Jul 06, 2016.
- Applicants must submit their applications by Aug 31, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Tuberculosis Elimination and Laboratory Cooperative Agreement is a continuation funding opportunity from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), specifically within NCHHSTP. It is focused on public health work in the area of tuberculosis (TB) elimination and the laboratory capacity that supports TB prevention, detection, and control activities. The funding instrument is a cooperative agreement, which generally means the CDC expects to have substantial involvement with award recipients during the project period, such as providing technical guidance, collaboration, and oversight tied to program implementation and performance.
This opportunity is identified by Funding Opportunity Number CDC RFA PS15-150103CONT17 and is categorized as a continuation award rather than a brand-new, open competition. The creation date for the listing is July 6, 2016, and the original closing date was August 31, 2016. The activity category is Health, and it is associated with CFDA number 93.116, which corresponds to CDC tuberculosis-related assistance. The listing indicates an expected total of 10 awards, suggesting support for a defined set of recipients or jurisdictions that are continuing previously funded TB elimination and laboratory efforts.
Eligibility is described broadly as "Others," with a note to consult the additional eligibility information in the full announcement for clarification. In practical terms, continuation cooperative agreements of this type often apply to established public health entities or organizations already engaged in CDC-supported TB prevention and laboratory work, but the precise eligible applicant types would be specified in the full eligibility section referenced in the source text.
The award ceiling is listed as 0, which typically indicates that a single maximum funding amount is not specified in the summarized fields and may instead be determined by factors such as recipient type, jurisdictional needs, approved work plans, congressional appropriations, or CDC programmatic decisions for the continuation period. Overall, the core purpose of the opportunity is to sustain and strengthen TB elimination activities and the laboratory infrastructure needed for timely diagnosis, surveillance, and response, using a cooperative agreement model that emphasizes ongoing collaboration between CDC and the funded recipients.
Frequently Asked Questions (FAQs)
What is the Tuberculosis Elimination and Laboratory Cooperative Agreement?
It is a continuation funding opportunity from the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), within NCHHSTP. The focus is on public health work related to tuberculosis (TB) elimination and the laboratory capacity that supports TB prevention, detection, and control activities.
Which federal agency is offering this opportunity?
The opportunity is offered by the CDC, which is part of HHS, and is housed within NCHHSTP.
What type of funding instrument is used?
This opportunity uses a cooperative agreement funding instrument. In general, a cooperative agreement means CDC expects to have substantial involvement with award recipients during the project period, such as technical guidance, collaboration, and oversight connected to implementation and performance.
What does "substantial involvement" from CDC typically mean in this context?
Based on the description provided, CDC involvement may include providing technical guidance, collaborating on program implementation, and conducting oversight tied to performance and program outcomes during the project period.
Is this a new competitive grant, or continuation funding?
This is identified as a continuation award, not a brand-new open competition. It is described as a continuation funding opportunity intended to support ongoing TB elimination and laboratory efforts.
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA PS15-150103CONT17.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.116, which corresponds to CDC tuberculosis-related assistance.
What is the activity category for this funding opportunity?
The activity category is Health.
When was this funding opportunity listing created?
The creation date for the listing is July 6, 2016.
What was the original application closing date?
The original closing date shown is August 31, 2016.
How many awards were expected?
The listing indicates an expected total of 10 awards.
Who is eligible to apply?
Eligibility is described broadly as "Others," with a note to consult the additional eligibility information in the full announcement for clarification. The precise eligible applicant types are not fully specified in the summary information provided.
Does the "Others" eligibility category explain which organizations qualify?
Not by itself. The summary points to additional eligibility information in the full announcement for the specific eligible applicant types.
Is this opportunity likely intended for existing CDC-funded TB programs?
The opportunity is categorized as a continuation award rather than an open competition, and the description notes it is a continuation funding opportunity. While continuation cooperative agreements often apply to established public health entities already engaged in CDC-supported TB and laboratory work, the exact eligibility and applicant pool would be defined in the full eligibility section referenced.
What is the purpose of the funding?
The core purpose is to sustain and strengthen TB elimination activities and the laboratory infrastructure needed for timely diagnosis, surveillance, and response, using a cooperative agreement model that emphasizes ongoing collaboration between CDC and funded recipients.
What kinds of activities does the opportunity emphasize?
It emphasizes TB elimination work and the supporting laboratory capacity that enables TB prevention, detection, and control activities, including timely diagnosis, surveillance, and response.
What is the award ceiling (maximum funding amount)?
The award ceiling is listed as 0 in the summarized fields, which typically indicates that a single maximum funding amount is not specified in the summary and may instead be determined by other factors for the continuation period.
If the award ceiling is listed as 0, does that mean no funding is available?
Not necessarily. In summarized listings, an award ceiling of 0 commonly signals that a maximum amount is not specified in that field. Funding levels may depend on factors such as recipient type, jurisdictional needs, approved work plans, appropriations, or CDC program decisions for the continuation period.
How might funding amounts be determined if no ceiling is listed?
Based on the description provided, amounts may be influenced by recipient type, jurisdictional needs, approved work plans, congressional appropriations, or CDC programmatic decisions for the continuation period.
What does it mean that this opportunity supports laboratory capacity?
It means the funding is intended not only for TB elimination activities but also for strengthening the laboratory infrastructure that supports TB prevention, detection, and control, including timely diagnosis and surveillance capabilities.
Where can applicants find the detailed eligibility requirements?
The summary indicates applicants should consult the additional eligibility information in the full announcement for clarification and specifics.
Browse more opportunities from the same agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP
Browse more opportunities from the same category: Health
Next opportunity: Rural Emergency Medical Communications Demonstration Project
Previous opportunity: BLM OR/WA, Malheur County Flood Damaged Roads, Vale District
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS15 150103CONT17
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS15 150103CONT17) also looked into and applied for these:
| Funding Opportunity |
|---|
| Comprehensive HIV Prevention Programs for Health Departments Apply for CDC RFA PS12 120106CONT17 Funding Number: CDC RFA PS12 120106CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Protecting and Improving Public Health Globally: Building and Strengthening Public Health Impact, Systems, Apply for CDC RFA GH15 1627A Funding Number: CDC RFA GH15 1627A Agency: Department of Health and Human Services, Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| The Role of Dysbiosis in Cardiovascular, Pulmonary and Hematological Complications During HIV Infection (R01) Apply for RFA HL 17 017 Funding Number: RFA HL 17 017 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $310,000 |
| Program Expansion Supplement to Cooperative Agreement on Immunization with the World Health Organization (WHO) Apply for CDC RFA GH13 13010201SUPP16 Funding Number: CDC RFA GH13 13010201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Advance Interoperable Health Information Technology Services to Support HIE Apply for IX IX 16 001 Funding Number: IX IX 16 001 Agency: Department of Health and Human Services, Office of the National Coordinator Category: Health Funding Amount: $575,000 |
| Rural Policy Analysis Program Apply for HRSA 17 003 Funding Number: HRSA 17 003 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $225,000 |
| Archiving and Sharing of Longitudinal Data Resources on Aging (U24) Apply for RFA AG 17 016 Funding Number: RFA AG 17 016 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $480,000 |
| Comprehensive High-Impact HIV Prevention Projects for Young Men of Color Who Have Sex with Men and Young Transgender Persons of Color Apply for CDC RFA PS17 1704 Funding Number: CDC RFA PS17 1704 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Integrated HIV/AIDS Program (IHAP) Apply for RFA 660 16 000002 Funding Number: RFA 660 16 000002 Agency: Agency for International Development, Democratic Republic of the Congo USAID-Kinshasa Category: Health Funding Amount: $70,000,000 |
| National Indian Health Outreach and Education I - Policy/Budget/Diabetes Apply for HHS 2016 IHS NIHOE 1 PBD 0001 Funding Number: HHS 2016 IHS NIHOE 1 PBD 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $825,000 |
| Poliomyelitis Eradication Initiative and Expanded Programme On Immunization, Apply for CDC RFA GH13 130105CONT17 Funding Number: CDC RFA GH13 130105CONT17 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| National Indian Health Outreach and Education II - Behavioral Health and HIV/AIDS Apply for HHS 2016 IHS NIHOE 2 BH HIV AIDS 0001 Funding Number: HHS 2016 IHS NIHOE 2 BH HIV AIDS 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $300,000 |
| Support for Activities to Eradicate Polio, Accelerate control of measles and rubella Apply for CDC RFA GH13 130205CONT17 Funding Number: CDC RFA GH13 130205CONT17 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Surveillance, intervention, and referral to services activities for infants with microcephaly or other adverse outcomes linked with the Zika virus-High Risk Local Areas Apply for CDC RFA DD16 1606 Funding Number: CDC RFA DD16 1606 Agency: Department of Health and Human Services, Centers for Disease Control - NCBDDD Category: Health Funding Amount: $720,000 |
| Alzheimer's Clinical Trials Consortium (ACTC) (U24) Apply for RFA AG 17 005 Funding Number: RFA AG 17 005 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $10,000,000 |
| IAEA Project Surge Expansion of Sterile Insect Technique (SIT) to Control Mosquito Populations Apply for ISN ISNIAEA 16 001 Funding Number: ISN ISNIAEA 16 001 Agency: Department of State, Bureau of International Security and Nonproliferat Category: Health Funding Amount: $12,000,000 |
| Tuskegee University Apology Commemoration Activities Apply for CDC RFA PS15 150403CONT17 Funding Number: CDC RFA PS15 150403CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Strengthening Regional Capabilities to Provide Health and Medical Assistance in the Americas Apply for EP IDS 16 008 Funding Number: EP IDS 16 008 Agency: Department of Health and Human Services, Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $150,000 |
| Program Expansion Supplement: Supporting Laboratory Diagnosis and Monitoring to Scale up and Improve HIV/AIDS care and treatment in the Kingdom of Lesotho under PEPFAR Apply for CDC RFA GH15 15460201SUPP16 Funding Number: CDC RFA GH15 15460201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $425,204 |
| National Indian Health Outreach and Education III - Health Reform Apply for HHS 2016 IHS NIHOE 3 HEALTH REFORM 0001 Funding Number: HHS 2016 IHS NIHOE 3 HEALTH REFORM 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $125,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS15 150103CONT17", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.